FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003237225> ?p ?o ?g. }

• W2003237225 endingPage "815" @default.
• W2003237225 startingPage "807" @default.
• W2003237225 abstract "Metabolic syndrome (MS) is an independent risk factor for chronic kidney diseases. As the renin-angiotensin system (RAS) is known to have a key role in renal damage, blockade of RAS may show renoprotective effects in MS. In this study, we investigated the renoprotective effects and mechanisms of action of an angiotensin receptor blocker (ARB) in spontaneously hypertensive (SHR/NDmcr-cp) rats as a model of MS. Male SHR/NDmcr-cp rats at 9 weeks of age were divided into three groups, each of which was treated for 12 weeks with vehicle, hydralazine (7.5 mg kg(-1) per day, p.o.) or ARB (olmesartan, 5 mg kg(-1) per day, p.o.). Blood pressure and urinary protein (UP) excretion were monitored. Kidney tissues were subjected to histological, immunohistochemical and molecular analyses. UP excretion increased with age in vehicle-treated SHR/NDmcr-cp rats compared with that in age-matched WKY/Izm rats. In addition, there was significant glomerular damage (increased glomerular sclerosis index, desmin staining and proliferating cell nuclear antigen (PCNA)-positive cells, electron microscopic findings of podocyte injury) and tubulointerstitial damage (increased tubulointerstitial fibrosis index, type IV collagen staining, PCNA-positive cells and expression of TGF-beta mRNA) in vehicle-treated SHR/NDmcr-cp rats compared with that in control rats. All the findings that related to glomerular and tubulointerstitial damage were significantly improved by ARB. Hydralazine mitigated the observed renal damage but was much less effective than ARB, despite similar decreases in blood pressure. There were no significant differences in glucose and lipid metabolism among vehicle-treated, hydralazine-treated and ARB-treated SHR/NDmcr-cp animals. These data suggest that RAS is deeply involved in the pathogenesis of renal damage in MS, and ARBs could provide a powerful renoprotective regimen for patients with MS." @default.
• W2003237225 created "2016-06-24" @default.
• W2003237225 creator A5021226292 @default.
• W2003237225 creator A5029984044 @default.
• W2003237225 creator A5035902259 @default.
• W2003237225 creator A5075757845 @default.
• W2003237225 creator A5078962175 @default.
• W2003237225 creator A5090348913 @default.
• W2003237225 date "2009-08-07" @default.
• W2003237225 modified "2023-10-09" @default.
• W2003237225 title "Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders" @default.
• W2003237225 cites W1826211555 @default.
• W2003237225 cites W1973464824 @default.
• W2003237225 cites W1982205510 @default.
• W2003237225 cites W2005482739 @default.
• W2003237225 cites W2006011717 @default.
• W2003237225 cites W2013216543 @default.
• W2003237225 cites W2016366089 @default.
• W2003237225 cites W2028605148 @default.
• W2003237225 cites W2029686762 @default.
• W2003237225 cites W2030877524 @default.
• W2003237225 cites W2032153017 @default.
• W2003237225 cites W2043360171 @default.
• W2003237225 cites W2044115563 @default.
• W2003237225 cites W2044773944 @default.
• W2003237225 cites W2052658828 @default.
• W2003237225 cites W2056976690 @default.
• W2003237225 cites W2062744722 @default.
• W2003237225 cites W2064527042 @default.
• W2003237225 cites W2066371543 @default.
• W2003237225 cites W2068604817 @default.
• W2003237225 cites W2073018303 @default.
• W2003237225 cites W2088283855 @default.
• W2003237225 cites W2090212259 @default.
• W2003237225 cites W2090969480 @default.
• W2003237225 cites W2097805169 @default.
• W2003237225 cites W2104491672 @default.
• W2003237225 cites W2104828404 @default.
• W2003237225 cites W2111560027 @default.
• W2003237225 cites W2111605358 @default.
• W2003237225 cites W2114316375 @default.
• W2003237225 cites W2123885645 @default.
• W2003237225 cites W2127635250 @default.
• W2003237225 cites W2131460202 @default.
• W2003237225 cites W2131780655 @default.
• W2003237225 cites W2133197823 @default.
• W2003237225 cites W2138256890 @default.
• W2003237225 cites W2144489880 @default.
• W2003237225 cites W2149482537 @default.
• W2003237225 cites W2151788147 @default.
• W2003237225 cites W2169730987 @default.
• W2003237225 cites W2186183384 @default.
• W2003237225 cites W2327112682 @default.
• W2003237225 doi "https://doi.org/10.1038/hr.2009.106" @default.
• W2003237225 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19662019" @default.
• W2003237225 hasPublicationYear "2009" @default.
• W2003237225 type Work @default.
• W2003237225 sameAs 2003237225 @default.
• W2003237225 citedByCount "20" @default.
• W2003237225 countsByYear W20032372252012 @default.
• W2003237225 countsByYear W20032372252015 @default.
• W2003237225 countsByYear W20032372252016 @default.
• W2003237225 countsByYear W20032372252017 @default.
• W2003237225 countsByYear W20032372252018 @default.
• W2003237225 countsByYear W20032372252020 @default.
• W2003237225 countsByYear W20032372252022 @default.
• W2003237225 countsByYear W20032372252023 @default.
• W2003237225 crossrefType "journal-article" @default.
• W2003237225 hasAuthorship W2003237225A5021226292 @default.
• W2003237225 hasAuthorship W2003237225A5029984044 @default.
• W2003237225 hasAuthorship W2003237225A5035902259 @default.
• W2003237225 hasAuthorship W2003237225A5075757845 @default.
• W2003237225 hasAuthorship W2003237225A5078962175 @default.
• W2003237225 hasAuthorship W2003237225A5090348913 @default.
• W2003237225 hasBestOaLocation W20032372251 @default.
• W2003237225 hasConcept C104849204 @default.
• W2003237225 hasConcept C126322002 @default.
• W2003237225 hasConcept C134018914 @default.
• W2003237225 hasConcept C2777390665 @default.
• W2003237225 hasConcept C2779561371 @default.
• W2003237225 hasConcept C2779766728 @default.
• W2003237225 hasConcept C2779922275 @default.
• W2003237225 hasConcept C2780036600 @default.
• W2003237225 hasConcept C2780091579 @default.
• W2003237225 hasConcept C2780521442 @default.
• W2003237225 hasConcept C2908929049 @default.
• W2003237225 hasConcept C2909763481 @default.
• W2003237225 hasConcept C71924100 @default.
• W2003237225 hasConcept C84393581 @default.
• W2003237225 hasConceptScore W2003237225C104849204 @default.
• W2003237225 hasConceptScore W2003237225C126322002 @default.
• W2003237225 hasConceptScore W2003237225C134018914 @default.
• W2003237225 hasConceptScore W2003237225C2777390665 @default.
• W2003237225 hasConceptScore W2003237225C2779561371 @default.
• W2003237225 hasConceptScore W2003237225C2779766728 @default.
• W2003237225 hasConceptScore W2003237225C2779922275 @default.
• W2003237225 hasConceptScore W2003237225C2780036600 @default.
• W2003237225 hasConceptScore W2003237225C2780091579 @default.

• next